2m 2m 2m 2m 2m 2m 2m
Pulse Bioscience (PLSE)
NASDAQ
$57.06+$1.94 (+3.51%)
Price as of Nov 11, 2026 7:50 PM EST- $4.1BMarket Cap
- 259.79%1-Year Change
- Medical Instruments & SuppliesIndustry
Pulse Bioscience (PLSE)
$57.06+$1.94 (+3.51%)
PLSE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.12 | ||
Change | -$3.05 (-5.24%) | ||
Open | $58.00 | ||
High | $58.00 | ||
Low | $51.80 | ||
Previous Close | $58.17 | ||
Volume | 496,318 | ||
30-Day Average Volume | 401,750 | ||
1-Week Change | 5.59% | ||
1-Month Change | 2.43% | ||
1-Year Change | 259.79% | ||
3-Year Change | 968.22% | ||
5-Year Change | 154.24% | ||
Fundamentals | |||
Shares Outstanding | 73.5M | ||
Total Assets | $201.6M | ||
Market Cap | $4.1B | ||
Enterprise Value | $4.0B | ||
Period: QTR TTM FY | |||
Revenue | $395,000.00 | ||
Net Income | -$23.1M | ||
Free Cash Flow | -$15.4M | ||
EBIT | -$23.1M | ||
EBITDA | -$22.9M | ||
Net Working Capital | $178.8M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -176 | ||
Enterprise Value/Revenue | 10,170 | ||
P/B | 22 | ||
P/E | -172 | ||
PEG | -16 | ||
Price/Free Cash Flow | -263 | ||
Price/Operating Cash Flow | -265 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue